Stock comparison
GILEAD SCIENCES, INC. is 5.7x more valuable than BIOGEN INC. by market capitalization ($167.49 B vs $29.37 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
GILD is larger
GILEAD SCIENCES, INC. is 5.7x more valuable than BIOGEN INC. by market capitalization ($167.49 B vs $29.37 B).
Market value leader
GILD
GILEAD SCIENCES, INC. is 5.7x more valuable than BIOGEN INC. by market capitalization ($167.49 B vs $29.37 B).
Revenue leader
GILD
GILD: $29.44B vs BIIB: $9.89B.
Profit leader
GILD
GILD: $8.51B vs BIIB: $1.29B.
Margin leader
GILD
GILD: 28.9% vs BIIB: 13.1% net margin.
| Metric | GILD | BIIB |
|---|---|---|
| Market cap | $167.49 B | $29.37 B |
| US-listed rank | #92 | #476 |
| Revenue (latest FY) | $29.44B | $9.89B |
| Net income (latest FY) | $8.51B | $1.29B |
| Net margin | 28.9% | 13.1% |
| P/E (trailing FY) | 19.7x | 22.7x |
| SEC filings | 968 | 2,690 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
GILEAD SCIENCES, INC. is 5.7x more valuable than BIOGEN INC. by market capitalization ($167.49 B vs $29.37 B).
In their latest fiscal years, GILEAD SCIENCES, INC. reported $29.44B in revenue while BIOGEN INC. reported $9.89B.
Full pages: GILEAD SCIENCES, INC. and BIOGEN INC., or browse the full rankings.